热休克蛋白70的过表达通过SIRT1/AMPK/eNOS途径保护小鼠免受肺缺血/再灌注损伤。
Over-expression of heat shock protein 70 protects mice against lung ischemia/reperfusion injury through SIRT1/AMPK/eNOS pathway.
作者信息
Liu Shumei, Xu Junping, Fang Chunfang, Shi Chunjing, Zhang Xin, Yu Bo, Yin Yantong
机构信息
Department of Respiratory Medicine, People's Hospital Liaocheng 252000, Shandong, China.
出版信息
Am J Transl Res. 2016 Oct 15;8(10):4394-4404. eCollection 2016.
Lung ischemia/reperfusion injury (LIRI) usually occurs during in lung transplantation and extracorporeal circulation operation and may develop into pulmonary infections, acute rejection and bronchiolitis obliterans syndrome. Recent studies have discovered the protective effect of heat shock protein 70 (HSP70) on various types of injuries. In the present study, we firstly explore the role of over-expressed HSP70 on the protection against LIRI. Lung Wet/Dry (W/D) ratio, biomarkers in the bronchoalveolar lavage fluid (BALF), lung histological changes and apoptosis markers, oxidative products and proinflammatory cytokines in the lung tissues were analyzed. Next, the expression of eNOS, SIRT1 and AMPK were measured. Finally, the changes of the lung W/D ratio and biomarkers in the BALF using the inhibitors of SIRT1/AMPK/eNOS pathway were evaluated. Mice exposed to LIRI procedure had significant increases in lung W/D ratio and biomarkers (protein level, LDH level, leukocytes and total cells) in BALF. LIRI also caused histological injury, demonstrated by hemorrhage, alveolar septal thickening and fibrin deposition. Apoptosis, oxidative products and proinflammatory cytokines in lung tissue were also induced by LIRI. The over-expression of HSP70 antagonized the impacts of LIRI by attenuating these parameters. It significantly increased the expression of eNOS, SIRT1 and AMPK, while the inhibition of SIRT1 and AMPK deactivated the eNOS expression. The lung W/D ratio and biomarkers in BALF were increased while mice were given inhibitors of eNOS, SIRT1 and AMPK. We concluded that over-expression of HSP70 had protective effect on LIRI and HSP70 might be involved in the protection through a SIRT1/AMPK/eNOS pathway.
肺缺血/再灌注损伤(LIRI)通常发生在肺移植和体外循环手术过程中,可能发展为肺部感染、急性排斥反应和闭塞性细支气管炎综合征。最近的研究发现热休克蛋白70(HSP70)对各种类型的损伤具有保护作用。在本研究中,我们首先探讨过表达的HSP70在预防LIRI中的作用。分析了肺湿/干(W/D)比值、支气管肺泡灌洗液(BALF)中的生物标志物、肺组织学变化以及肺组织中的凋亡标志物、氧化产物和促炎细胞因子。接下来,检测了eNOS、SIRT1和AMPK的表达。最后,评估了使用SIRT1/AMPK/eNOS途径抑制剂后肺W/D比值和BALF中生物标志物的变化。经历LIRI过程的小鼠肺W/D比值和BALF中的生物标志物(蛋白水平、乳酸脱氢酶水平、白细胞和总细胞)显著增加。LIRI还导致组织学损伤,表现为出血、肺泡间隔增厚和纤维蛋白沉积。LIRI还诱导了肺组织中的凋亡、氧化产物和促炎细胞因子。HSP70的过表达通过减弱这些参数拮抗了LIRI的影响。它显著增加了eNOS、SIRT1和AMPK的表达,而抑制SIRT1和AMPK则使eNOS表达失活。当给小鼠给予eNOS、SIRT1和AMPK抑制剂时,肺W/D比值和BALF中的生物标志物增加。我们得出结论,HSP70的过表达对LIRI具有保护作用,并且HSP70可能通过SIRT1/AMPK/eNOS途径参与保护作用。